Alcohol Pharmacotherapy and the Treatment and Prevention of HIV/AIDS
Published Date
Agency
CFDA
93.273
Contact Information
Judy Fox, 301-443-4704; jfox@mail.nih.gov
Deadline
Department
Eligiblity
State, local and tribal governments, nonprofit and for-profit organizations, institutions of higher education, independent school districts and public housing authorities
Guide Page Reference
None
Program Area
Programe Purpose
To test innovative single and combined pharmacological therapies for alcohol use disorders in HIV+ populations for the purpose of improving adherence to antiretroviral medications, reducing the rate of viral mutation and toxicity related to alcohol-ARV interactions, and reducing sexual risk-taking
